We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.49B
AUM Growth
-$343M
(-3.9%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-2.94%
Top 10 Holdings %
Top 10 Hldgs %
16.07%
Holding
2,271
New
51
Increased
125
Reduced
935
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.3M |
| 2 |
Baxter International
BAX
|
+$9.74M |
| 3 |
Archer Daniels Midland
ADM
|
+$6.88M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$6.54M |
| 5 |
Nektar Therapeutics
NKTR
|
+$4.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$17.1M |
| 2 |
Apple
AAPL
|
+$10.6M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$10.1M |
| 4 |
AvalonBay Communities
AVB
|
+$7.62M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$6.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.14% |
| 2 | Financials | 17.01% |
| 3 | Healthcare | 12.77% |
| 4 | Industrials | 11.29% |
| 5 | Consumer Discretionary | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
West Pharmaceutical
WST
$24.4B
| $4.08M | 0.05% |
46,171
-810
| -2% | -$75.8K |
|
427
Silicon Laboratories
SLAB
$7.28B
| $4.07M | 0.05% |
45,301
-278
| -0.6% | -$26.2K |
|
428
Expedia Group
EXPE
$39.4B
| $4.07M | 0.05% |
36,819
-1,217
| -3% | -$142K |
|
429
First American
FAF
$7.56B
| $4.05M | 0.05% |
69,096
-958
| -1% | -$56.1K |
|
430
Texas Roadhouse
TXRH
$13.6B
| $4.05M | 0.05% |
70,178
-2,242
| -3% | -$129K |
|
431
Loews
L
$23B
| $4.04M | 0.05% |
81,144
-4,256
| -5% | -$215K |
|
432
Carlisle Companies
CSL
$14.9B
| $4.03M | 0.05% |
38,560
-663
| -2% | -$72.7K |
|
433
Dana Inc
DAN
$3.26B
| $4.02M | 0.05% |
156,181
-1,027
| -0.7% | -$30.4K |
|
434
Ziff Davis
ZD
$1.92B
| $4.02M | 0.05% |
58,522
-1,451
| -2% | -$98.2K |
|
435
Molina Healthcare
MOH
$10.7B
| $4.01M | 0.05% |
49,393
+1,753
| +4% | +$141K |
|
|
ALE
436
DELISTED
Allete
ALE
| $3.99M | 0.05% |
55,178
+31,739
| +135% | +$2.24M |
|
|
FLG
437
Flagstar Bank National Association
FLG
$5.92B
| $3.99M | 0.05% |
101,974
-1,169
| -1% | -$48.3K |
|
438
RPM International
RPM
$14.5B
| $3.98M | 0.05% |
83,415
-1,075
| -1% | -$54.7K |
|
439
Cousins Properties
CUZ
$4.93B
| $3.97M | 0.05% |
114,302
-908
| -0.8% | -$31.7K |
|
440
Genuine Parts
GPC
$18.7B
| $3.97M | 0.05% |
44,158
-1,205
| -3% | -$116K |
|
|
MDSO
441
DELISTED
Medidata Solutions, Inc.
MDSO
| $3.96M | 0.05% |
63,097
-24
| -0% | -$1.6K |
|
442
Ciena
CIEN
$62.7B
| $3.96M | 0.05% |
152,834
-4,082
| -3% | -$96.1K |
|
|
ANSS
443
DELISTED
Ansys
ANSS
| $3.96M | 0.05% |
25,240
-1,016
| -4% | -$162K |
|
444
Gentex
GNTX
$4.99B
| $3.94M | 0.05% |
171,254
-8,374
| -5% | -$191K |
|
445
C.H. Robinson
CHRW
$17.5B
| $3.94M | 0.05% |
42,056
-1,077
| -2% | -$99.2K |
|
446
Martin Marietta Materials
MLM
$32.7B
| $3.92M | 0.05% |
18,900
-550
| -3% | -$119K |
|
447
WEX
WEX
$6.78B
| $3.91M | 0.05% |
24,975
-274
| -1% | -$41.2K |
|
448
Reliance Steel & Aluminium
RS
$21.7B
| $3.9M | 0.05% |
45,450
-684
| -1% | -$61.1K |
|
|
GGP
449
DELISTED
GGP Inc.
GGP
| $3.89M | 0.05% |
190,082
-3,095
| -2% | -$68.5K |
|
|
PACW
450
DELISTED
PacWest Bancorp
PACW
| $3.89M | 0.05% |
78,492
-3,087
| -4% | -$161K |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q1 2018 Portfolio in Review
As of Q1 2018, MetLife Investment Management held 2,271 positions worth $8.49B, down 3.9% from $8.84B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
MetLife Investment Management's Q1 2018 filing shows 51 new, 125 increased, 935 reduced and 90 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M. The largest sale was Bank of New York Mellon, an estimated $17.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q1 2018 buy was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $25.3M increase.
- MetLife Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $10.6M.
- MetLife Investment Management fully exited Bank of New York Mellon in Q1 2018, selling an estimated $17.1M.
- MetLife Investment Management's ten largest holdings make up 16% of its $8.49B portfolio in Q1 2018.
- MetLife Investment Management opened 51 new positions and closed 90 in Q1 2018.
- MetLife Investment Management's portfolio value fell 3.9% quarter-over-quarter to $8.49B.
Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.